Introduction of a new recombinant vaccine based on GRP78 for breast cancer immunotherapy and evaluation in a mouse model.
Hamed ZareHamid BakheradArman Nasr EsfahaniMohamad NorouziHossein AghamollaeiSeyed Latif Mousavi GargariFatemeh MahmoodiMahdi AliomraniWalead EbrahimizadehPublished in: BioImpacts : BI (2023)
cGRP78 vaccines generated potent immunotherapeutic effects in a breast cancer mouse model. This novel strategy of targeting the GRP78 protein can promote the development of cancer vaccines and immunotherapies for breast cancer malignancies.